electroCore,

electroCore, Inventory Turnover

The Inventory Turnover Ratio of electroCore, (ECOR) as of Oct 19, 2026 is 2.60. In the previous year, Inventory Turnover Ratio was 2.26 — a change of 15.22% (higher).

Inventory Turnover

2.60

YoY

15.22%

Last updated:

Inventory Turnover Ratio of electroCore, is 2025 2.60 . Inventory Turnover Ratio of electroCore, was 2024 2.26 . It decreases by 15.22% higher compared to the previous year.

The electroCore, Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2018
0.30 USD
Jan 1, 2019
1.27 USD
Jan 1, 2020
1.98 USD
Jan 1, 2021
1.02 USD
Jan 1, 2022
0.82 USD
Jan 1, 2023
1.30 USD
Jan 1, 2024
2.26 USD
Jan 1, 2025
2.60 USD
The electroCore, Inventory Turnover history
YEARInventory TurnoverYoY
2.60+15.22%
2.26+73.97%
1.30+58.73%
0.82-19.64%
1.02-48.67%
1.98+56.13%
1.27+327.69%
0.30-81.23%
1.58-38.03%
2.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Inventory Turnover Ratio of electroCore, is 2.60 in 2025.

Inventory Turnover Ratio of electroCore, changed from 2.26 to 2.60, representing a 15.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio electroCore, since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's electroCore, with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — electroCore,

All Key Metrics — electroCore,